there's also a likely neurologix phase 3 coming up and isn't oxford biopharma or something like that showing good results? i think more than 3 options in the pipeline.
and more entering soon.
i don't understand what "looking good" means. did your neuro actually see those patients and if so was he wearing rose colored glasses? i'd also closely check out their other clinical trial outcomes. and i'd closely study ceregene's phase2 results and ask if the affects are still lasting and even ask to talk to a few subjects.

i'd say young children makes it a bad decision, too much at risk to be a guinea pig unless phase2 had terrific results. when the right time comes, you'll not have any doubts.
none of my business but have you tried the long lasting requip?